-+ 0.00%
-+ 0.00%
-+ 0.00%

Candel Therapeutics To Present Data About Solid Tumors At Society For Immunotherapy Of Cancer In Maryland

Benzinga·11/04/2025 14:03:18
Listen to the news

Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company developing multimodal biological immunotherapies to help patients fight cancer, today announced it will deliver three presentations at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, taking place November 5–9, 2025, in National Harbor, Maryland.